Ohio Public Employees Retirement System (OPERS)’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$473K Hold
37,502
﹤0.01% 1497
2025
Q4
$386K Buy
37,502
+9,300
+33% +$78.4K ﹤0.01% 1555
2025
Q3
$164K Buy
28,202
+13,200
+88% +$77.2K ﹤0.01% 1712
2025
Q2
$101K Hold
15,002
﹤0.01% 1770
2025
Q1
$136K Sell
15,002
-2,257
-13% -$28.1K ﹤0.01% 1709
2024
Q4
$298K Buy
17,259
+1,000
+6% +$18.1K ﹤0.01% 1605
2024
Q3
$260K Buy
16,259
+7,659
+89% +$121K ﹤0.01% 1510
2024
Q2
$123K Buy
+8,600
New +$122K ﹤0.01% 1411

Other funds holding TRDA

Ohio Public Employees Retirement System (OPERS)'s TRDA Position: Q1 2026 in Review

Ohio Public Employees Retirement System (OPERS) held its Entrada Therapeutics (TRDA) position steady in Q1 2026 at 37,502 shares worth $473K. The position accounts for ﹤0.01% of the portfolio, ranked #1497.

Ohio Public Employees Retirement System (OPERS) first reported a position in TRDA in Q2 2024 and has held it in 8 quarters since. 120 funds tracked by Wall St. Rank hold TRDA as of Q1 2026.

  • Ohio Public Employees Retirement System (OPERS) held 37,502 shares of Entrada Therapeutics worth $473K as of Q1 2026.
  • Ohio Public Employees Retirement System (OPERS) left its Entrada Therapeutics share count unchanged in Q1 2026.
  • Entrada Therapeutics made up ﹤0.01% of Ohio Public Employees Retirement System (OPERS)'s portfolio in Q1 2026, its #1497 holding.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Entrada Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 120 funds tracked by Wall St. Rank held Entrada Therapeutics as of Q1 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q1 2026, filed 14 May 2026.